Trials / Completed
CompletedNCT01277822
Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)
The 8 Weeks, Multicenter, Randomized, Double-blind, Clinical Study To Evaluate Efficacy Of Treatment With Losartan/Amlodipine 100/5 mg Combination Compared To Amlodipine 10 mg Monotherapy In Hypertensive Patients Who Are Not Appropriately Respond To Amlodipine 5 mg Monotherapy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 334 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study will determine whether using losartan and amlodipine together will be non-inferior in lowering blood pressure than amlodipine alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Losartan (+) amlodipine | One tablet containing 100 mg losartan potassium and 5 mg amlodipine camsylate, orally, once daily, for 8 weeks. |
| DRUG | Placebo to match losartan/amlodipine tablets | One tablet containing placebo, orally, once daily, for 8 weeks. |
| DRUG | Amlodipine camsylate | 2 tablets each containing 5 mg amlodipine, orally, once daily, for 8 weeks. |
| DRUG | Placebo to match amlodipine | 2 tablets containing placebo, orally, once daily, for 8 weeks. |
Timeline
- Start date
- 2011-05-30
- Primary completion
- 2013-04-22
- Completion
- 2013-04-22
- First posted
- 2011-01-17
- Last updated
- 2024-06-20
- Results posted
- 2014-04-24
Source: ClinicalTrials.gov record NCT01277822. Inclusion in this directory is not an endorsement.